NCT04828083View on ClinicalTrials.gov

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

November 30, 2024

Conditions
Arthroplasty, Replacement, KneeTotal Knee Arthroplasty
Interventions
DRUG

Lidocaine IV

Intravenous lidocaine of 1.5 mg/kg bolus followed by a 1.5 mg/kg/h infusion continuing to the end of phase 1 of post anesthesia care unit

DRUG

Saline IV

Intravenous saline of 1.5 mg/kg bolus followed by a 1.5 mg/kg/h infusion continuing to the end of phase 1 of post anesthesia care unit

Trial Locations (1)

02903

RECRUITING

Rhode Island Hospital, Providence

All Listed Sponsors
lead

Rhode Island Hospital

OTHER

NCT04828083 - Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter